Circ_0110805 Knockdown Enhances Cisplatin Sensitivity and Inhibits Gastric Cancer Progression by miR-299-3p/ENDOPDI Axis

BACKGROUND: Gastric cancer is a prevalent primary stomach tumor. Cisplatin is frequently used to treat gastric cancer. However, the resistance of cisplatin in gastric cancer often occurs, which brings a heavy burden to gastric cancer treatment. METHODS: In this study, we revealed a novel underlying...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xi, Zhang, Qunxiong, Guan, Bugao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654533/
https://www.ncbi.nlm.nih.gov/pubmed/33192077
http://dx.doi.org/10.2147/OTT.S279563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654533/
https://www.ncbi.nlm.nih.gov/pubmed/33192077
http://dx.doi.org/10.2147/OTT.S279563

Ejemplares similares